NCPA: We’re on the Verge of Groundbreaking PBM Reforms
17 déc. 2024 19h38 HE
|
National Community Pharmacists Association
Alexandria, Va., Dec. 17, 2024 (GLOBE NEWSWIRE) -- The National Community Pharmacists Association (NCPA), which has lobbied for years for fairer prescription reimbursements and pharmacy benefit...
A Letter from the Desk of CBIH
09 déc. 2024 08h00 HE
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings CEO Dante Picazo Addresses Cannabis Reclassification and DEA Hearings
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients
02 déc. 2024 17h22 HE
|
Serina Therapeutics, Inc.
HUNTSVILLE, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced a $10 million equity financing with...
Vosita Announces New Features and Exciting Giveaway
12 nov. 2024 08h15 HE
|
Vosita Healthcare
Vosita launches v2.7 with enhanced features and a Mini Cybertruck Giveaway! Create an account by Dec 20 for a chance to win.
Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA
31 oct. 2024 15h28 HE
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research (FSR) hosts Externally Led Patient-Focused Drug Development (EL-PFDD) meeting for Sarcoidosis
New Treatments, Novel Research Drive Better Survival Rates for Canadians with Lung Cancer, Offering Hope to Thousands: Lung Health Foundation
31 oct. 2024 08h26 HE
|
Lung Health Foundation
New treatments and novel research are driving better survival rates for Canadians with Lung Cancer, offering hope to thousands of patients.
Tennr lands $37m while tearing through the paper mountain in healthcare with leading document reading model
22 oct. 2024 10h00 HE
|
Tennr
New York, Oct. 22, 2024 (GLOBE NEWSWIRE) -- When a doctor refers a patient to a specialist, they want that patient to receive quality care—and quickly. But messy documentation, lengthy clinical...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
17 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
Scathing FTC Interim Report on PBMs Warrants Further Investigations, Immediate Action by Policymakers and Regulators
09 juil. 2024 13h13 HE
|
National Community Pharmacists Association
Alexandria, Va., July 09, 2024 (GLOBE NEWSWIRE) -- The interim report published today by the Federal Trade Commission – titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs...
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
06 juin 2024 09h00 HE
|
Tiziana Life Sciences Ltd.
Qualitative improvements in PET imaging seen in 80% of non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access patients receiving intranasal foralumab for at least 6-months.FDA...